Blockade of porcine carotid vascular responses to sumatriptan by GR127935, a selective 5‐HT1D receptor antagonist
Open Access
- 1 May 1996
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 118 (1) , 85-92
- https://doi.org/10.1111/j.1476-5381.1996.tb15370.x
Abstract
. It has previously been shown that the antimigraine drug, sumatriptan, a putative 5‐HT1D receptor agonist, decreases porcine common carotid and arteriovenous anastomotic blood flows, but slightly increases the arteriolar (capillary) blood flow to the skin and ears. Interestingly, such responses, being mediated by 5‐HT1‐like receptors, are resistant to blockade by metergoline, which, in addition to displaying a very high affinity for (and occasionally intrinsic efficacy at) the 5‐HT1D receptor subtypes, blocks (with lower potency than methiothepin) some 5‐HT1D receptor‐mediated vascular responses. These findings raise doubts whether sumatriptan‐sensitive 5‐HT1‐like receptors mediating changes in the distribution of porcine carotid blood flow are identical to cloned 5‐HT1D receptors. With the recent advent of the potent and selective 5‐HT1D receptor antagonist, GR127935, we have examined in the present study whether the carotid vascular effects of sumatriptan in the pig are amenable to blockade by GR127935. . In animals pretreated with saline, sumatriptan (30, 100 and 300 μm kg−1, i.v.) reduced the total carotid and arteriovenous anastomotic blood flows in a dose dependent manner. In contrast, sumatriptan increased blood flow to the skin, ears and fat, although the total capillary fraction was not significantly affected. . While GR127935 pretreatment (0.25 and 0.5 mg kg−1) itself slightly reduced the total carotid and arteriovenous anastomotic blood flows, carotid vasoconstrictor responses to sumatriptan were either partly (0.25 mg kg−1) or completely (0.5 mg kg−1) blocked by the compound. In GR127935 pretreated animals, the sumatriptan‐induced increases in blood flow to the skin, ears and fat were also attenuated. . Taken together, the results suggest that arteriovenous anastomotic constriction and, possibly, arteriolar dilatation in the skin, ears and fat by sumatriptan are mediated by 5‐HT1D receptors. Therefore, vascular 5‐HT1‐like receptors in the porcine carotid bed appear to be identical to 5‐HT1D receptors.Keywords
This publication has 36 references indexed in Scilit:
- The 5-HT1Dreceptor antagonist GR 127,935 is an agonist at cloned human 5-HT1Dα receptor sitesNeuropharmacology, 1995
- Evolution of a Novel Series of [(N,N-Dimethylamino)propyl]- and Piperazinylbenzanilides as the First Selective 5-HT1D AntagonistsJournal of Medicinal Chemistry, 1994
- 5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphénucleusNeuropharmacology, 1994
- 5‐Hydroxytryptamine receptor characterizations of human cerebral, middle meningeal and temporal arteries: regional differencesActa Physiologica Scandinavica, 1993
- Agonist activity of sumatriptan and metergoline at the human 5-HT1Dβ receptor: further evidence for a role of the 5-HT1D receptor in the action of sumatriptanEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Effects of S9977 and dihydroergotamine in an animal experimental model for migrainePharmacological Research, 1992
- 5-Hydroxytryptamine: a chameleon in the heartTrends in Pharmacological Sciences, 1991
- Cardiovascular Effects of Serotonin Agonists and AntagonistsJournal of Cardiovascular Pharmacology, 1990
- Systemic and Regional Hemodynamic Effects of the Putative 5-HT1AReceptor Agonist Flesinoxan in the CatJournal of Cardiovascular Pharmacology, 1989
- Computer programs for the radioactive microsphere technique: Determination of regional blood flows and other haemodynamic variables in different experimental circumstancesComputer Programs in Biomedicine, 1980